PV Loop & Coarctation Study
NCT05362721 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2026-04-08
Summary
Coarctation of the aorta accounts for 4-7% of all congenital heart disease. While stent therapy, when feasible, is the standard of care for coarctation, it may not completely improve the work (and afterload) of the heart due to its effects on the elasticity of the aorta. This study will provide the information needed to understand the effects of current management on the cardiac mechanics and work.
Conditions
- Coarctation of Aorta
Interventions
- DIAGNOSTIC_TEST
-
Pressure-volume loop catheter
The cardiac catheterization procedure will be done according to standard protocol as part of the standard clinical care. This has become the standard of care in any patient in which it feasible and is performed with low risk.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Gurumurthy Hiremath · University of Minnesota
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-04
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Allogeneic Left Atrial and Pulmonary Vein Transplant for Pulmonary Vein Stenosis
NCT03456193 ·Status: SUSPENDED ·Phase: NA
-
Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
NCT00572091 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pediatric REPlAcement of the PulmonaRy ValvE in Tetralogy of Fallot -
NCT03634072 ·Status: TERMINATED ·Phase: NA
-
Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device Under a Continued Access Protocol
NCT01242891 ·Status: APPROVED_FOR_MARKETING
-
Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
NCT07140562 ·Status: RECRUITING ·Phase: NA
-
OPTImal Treatment of Sinus VENOSUS Defect
NCT05865119 ·Status: RECRUITING ·Phase: NA
-
Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring
NCT06378996 ·Status: RECRUITING ·Phase: NA
-
Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
NCT00583791 ·Status: COMPLETED ·Phase: NA
-
Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT
NCT05524324 ·Status: RECRUITING ·Phase: NA
-
Rivet PVS Therapy in Group 2 PH-HFpEF
NCT05205265 ·Status: WITHDRAWN ·Phase: NA
-
Xeltis Pulmonary Valved Conduit Safety and Performance Study
NCT03405636 ·Status: WITHDRAWN ·Phase: NA
-
Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort
NCT00740870 ·Status: COMPLETED ·Phase: NA
-
Rivet PVS Therapy in Group 2 PH-HFpEF Canada
NCT05332873 ·Status: WITHDRAWN ·Phase: NA
-
An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
NCT06823635 ·Status: NOT_YET_RECRUITING
-
Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function
NCT01899573 ·Status: COMPLETED ·Phase: NA
-
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
NCT04467671 ·Status: RECRUITING ·Phase: PHASE2
-
Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)
NCT04396041 ·Status: COMPLETED
-
Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)
NCT06754839 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device
NCT00583661 ·Status: COMPLETED ·Phase: NA
-
Multicentre Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation
NCT01920698 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Efficacy of the BACE™ Device in the Treatment of Functional Mitral Valve Regurgitation [FMR
NCT02701972 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery
NCT01034007 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
NCT03441971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects
NCT01711983 ·Status: COMPLETED ·Phase: NA
-
Veno-arterial Extracorporeal Membrane Oxygenation Prior to Left Ventricular Assist Device Implantation.
NCT03583970 ·Status: UNKNOWN